Shandong Xinhua Pharmaceutical Company Limited (HKG: 0719)
Hong Kong
· Delayed Price · Currency is HKD
5.99
+0.34 (6.02%)
Jan 3, 2025, 4:08 PM HKT
Shandong Xinhua Pharmaceutical Company Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 8,193 | 7,956 | 7,295 | 6,360 | 5,949 | 5,540 | Upgrade
|
Other Revenue | 144.78 | 144.78 | 207.82 | 200.54 | 56.85 | 66.37 | Upgrade
|
Revenue | 8,337 | 8,101 | 7,503 | 6,560 | 6,006 | 5,606 | Upgrade
|
Revenue Growth (YoY) | -2.45% | 7.97% | 14.37% | 9.23% | 7.13% | 6.89% | Upgrade
|
Cost of Revenue | 6,324 | 5,779 | 5,515 | 4,824 | 4,244 | 3,817 | Upgrade
|
Gross Profit | 2,013 | 2,321 | 1,988 | 1,736 | 1,762 | 1,789 | Upgrade
|
Selling, General & Admin | 1,081 | 1,287 | 1,106 | 929.12 | 943.96 | 1,105 | Upgrade
|
Research & Development | 404.63 | 419.24 | 345.66 | 341.37 | 298.35 | 235.4 | Upgrade
|
Other Operating Expenses | 35.31 | 92.18 | 65.31 | 59.27 | 60.28 | 58.19 | Upgrade
|
Operating Expenses | 1,537 | 1,809 | 1,522 | 1,332 | 1,303 | 1,399 | Upgrade
|
Operating Income | 476.75 | 512.15 | 465.87 | 403.67 | 458.77 | 390.33 | Upgrade
|
Interest Expense | -37.56 | -41.15 | -49.71 | -53.1 | -59.76 | -55.32 | Upgrade
|
Interest & Investment Income | 19.21 | 21.88 | 18.83 | 16.79 | 11.58 | 8.76 | Upgrade
|
Currency Exchange Gain (Loss) | 15.42 | 15.42 | 10.53 | -4.18 | -24.78 | 8.11 | Upgrade
|
Other Non Operating Income (Expenses) | -10.74 | -2.72 | -3.38 | -2.45 | -4.46 | -4.46 | Upgrade
|
EBT Excluding Unusual Items | 463.08 | 505.59 | 442.15 | 360.72 | 381.35 | 347.43 | Upgrade
|
Gain (Loss) on Sale of Assets | 1.65 | 8.73 | 5.54 | 2.07 | 2.49 | 0.84 | Upgrade
|
Asset Writedown | -14.26 | -10.29 | -2.61 | -1.88 | -4.43 | -2.65 | Upgrade
|
Other Unusual Items | 28.65 | 28.65 | 26.7 | 60.32 | 32.23 | 35.78 | Upgrade
|
Pretax Income | 479.13 | 532.69 | 471.77 | 421.23 | 411.64 | 381.39 | Upgrade
|
Income Tax Expense | 17.86 | 26.58 | 45.66 | 59.16 | 64.52 | 58.28 | Upgrade
|
Earnings From Continuing Operations | 461.27 | 506.11 | 426.11 | 362.07 | 347.11 | 323.12 | Upgrade
|
Minority Interest in Earnings | -12.64 | -9.59 | -15.05 | -13.53 | -22.25 | -23.15 | Upgrade
|
Net Income | 448.62 | 496.51 | 411.06 | 348.55 | 324.86 | 299.97 | Upgrade
|
Net Income to Common | 448.62 | 496.51 | 411.06 | 348.55 | 324.86 | 299.97 | Upgrade
|
Net Income Growth | -11.96% | 20.79% | 17.94% | 7.29% | 8.30% | 17.49% | Upgrade
|
Shares Outstanding (Basic) | 684 | 674 | 661 | 627 | 622 | 622 | Upgrade
|
Shares Outstanding (Diluted) | 692 | 692 | 671 | 627 | 627 | 622 | Upgrade
|
Shares Change (YoY) | 0.91% | 3.20% | 6.92% | -0.02% | 0.86% | -0.14% | Upgrade
|
EPS (Basic) | 0.66 | 0.74 | 0.62 | 0.56 | 0.52 | 0.48 | Upgrade
|
EPS (Diluted) | 0.65 | 0.72 | 0.61 | 0.56 | 0.52 | 0.48 | Upgrade
|
EPS Growth | -12.08% | 18.03% | 9.75% | 6.89% | 8.33% | 17.07% | Upgrade
|
Free Cash Flow | 169.05 | -59.85 | 513.48 | 9.89 | 140 | -18.24 | Upgrade
|
Free Cash Flow Per Share | 0.24 | -0.09 | 0.77 | 0.02 | 0.22 | -0.03 | Upgrade
|
Dividend Per Share | 0.275 | 0.250 | 0.200 | 0.150 | 0.150 | 0.120 | Upgrade
|
Dividend Growth | 37.50% | 25.00% | 33.33% | 0% | 25.00% | 20.00% | Upgrade
|
Gross Margin | 24.15% | 28.66% | 26.50% | 26.46% | 29.33% | 31.92% | Upgrade
|
Operating Margin | 5.72% | 6.32% | 6.21% | 6.15% | 7.64% | 6.96% | Upgrade
|
Profit Margin | 5.38% | 6.13% | 5.48% | 5.31% | 5.41% | 5.35% | Upgrade
|
Free Cash Flow Margin | 2.03% | -0.74% | 6.84% | 0.15% | 2.33% | -0.33% | Upgrade
|
EBITDA | 1,006 | 1,023 | 952.48 | 840.2 | 842.97 | 734.07 | Upgrade
|
EBITDA Margin | 12.07% | 12.63% | 12.69% | 12.81% | 14.04% | 13.09% | Upgrade
|
D&A For EBITDA | 529.7 | 511.23 | 486.61 | 436.53 | 384.2 | 343.74 | Upgrade
|
EBIT | 476.75 | 512.15 | 465.87 | 403.67 | 458.77 | 390.33 | Upgrade
|
EBIT Margin | 5.72% | 6.32% | 6.21% | 6.15% | 7.64% | 6.96% | Upgrade
|
Effective Tax Rate | 3.73% | 4.99% | 9.68% | 14.04% | 15.68% | 15.28% | Upgrade
|
Revenue as Reported | 8,337 | 8,101 | 7,503 | - | 6,006 | 5,606 | Upgrade
|
Advertising Expenses | - | 8.95 | 8.18 | 11.33 | 12.84 | 14.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.